Dofetilide: A Review of its Use in Atrial Fibrillation and Atrial Flutter

ISSN： 0012-6667

Source： Drugs, Vol.58, Iss.6, 1999-12, pp. : 1043-1059

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Atrial Fibrillation and Flutter: Focus on Oral Dofetilide, a New Selective Class III Antiarrhythmic Agent

Heart Drug, Vol. 1, Iss. 6, 2002-02 ,pp. : 320-331

Karger

Access to resources Recommend Favorite

Lacosamide: Atrial flutter and atrial fibrillation: case report

Reactions Weekly, Vol. 1, Iss. 1316, 2010-01 ,pp. : 28-29

Adis International

Access to resources Recommend Favorite

New antiarrhythmic agents for atrial fibrillation and atrial flutter

By Pecini Redi Elming Hanne Pedersen Ole Dyg Torp-Pedersen Christian

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 311-322

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Therapy in Children with Atrial Fibrillation and Atrial Flutter

Current Pharmaceutical Design, Vol. 14, Iss. 8, 2008-03 ,pp. : 770-775

Bentham Science Publishers

Access to resources Recommend Favorite

Intravenous Vernakalant: A Review of its Use in the Management of Recent-Onset Atrial Fibrillation

By Duggan Sean T. Scott Lesley J.

Drugs, Vol. 71, Iss. 2, 2011-01 ,pp. : 237-252

Adis International

Access to resources Recommend Favorite